✦ LIBER ✦

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations

✍ Scribed by Christoph Hatz; Jakob P. Cramer; André Vertruyen; Tino F. Schwarz; Frank von Sonnenburg; Astrid Borkowski; Maria Lattanzi; Anne Katrin Hilbert; Giovanni Della Cioppa; Geert Leroux-Roels

Book ID: 116964984
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 376 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.05.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of the immunogenicity and saf

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects

✍ Hiroyuki Fukase; Hidetoshi Furuie; Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Dose ranging of adjuvant and antigen in

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

✍ Wendy Keitel; Nicola Groth; Maria Lattanzi; Michaela Praus; Anne Katrin Hilbert; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 950 KB

Efficacy, safety, and immunogenicity of

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

✍ P Noel Barrett; Gregory Berezuk; Sandor Fritsch; Gerald Aichinger; Mary Kate Har 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 209 KB

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

✍ M. Loebermann; G. Anders; G. Brestrich; C. Fritzsche; S. Klammt; D. Boršo; S. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A clinical study to assess the immunogen

A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza

✍ Hsiang-Chi Kung; Kuo-Chin Huang; Tsui-Mai Kao; Yi-Chien Lee; Feng-Yee Chang; Nin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 630 KB

Safety and immunogenicity of an MF59®-ad

Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB